Document Classification

Section Type: RESULTS

Text: At the end of the study period, the ALC-treated patients in the HE1 group showed significantly better improvement than did the placebo group in mental fatigue score (-1. 7 compared with -0. 3 ; P < 0. 05), the fatigue severity scale (-6. 4 compared with 2. 3 ; P < 0. 001), 7-d Physical Activity Recall questionnaire score (17. 1 compared with -2. 5 ; P < 0. 001), and Short Physical Performance Battery (2. 1 compared with 0. 2 ; P < 0. 001) ; the HE2 group showed significantly better improvement in the fatigue severity scale (-8. 1 compared with -5. 1 ; P < 0. 001) and 6-min walk test (19. 9 compared with 2. 3 ; P < 0. 05).